• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.17% Nasdaq Up0.39%

    Nxstage Medical, Inc. (NXTM)

    19.90 Up 0.05(0.25%) 12:13PM EST - Nasdaq Real Time Price
    ProfileGet Profile for:
    Nxstage Medical, Inc.
    350 Merrimack Street
    Lawrence, MA 01843
    United States - Map
    Phone: 978-687-4700
    Website: http://www.nxstage.com

    Index Membership:N/A
    Industry:Medical Appliances & Equipment
    Full Time Employees:3,400

    Business Summary 

    NxStage Medical, Inc., a medical device company, develops, manufactures, and markets products for the treatment of kidney failure, fluid overload, and related blood treatments and procedures. Its primary product includes the System One, a portable hemodialysis system used for the treatment of acute and chronic kidney failure, and fluid overload. The company operates in three segments: System One, In-Center, and Services. The System One segment engages in the sale and rental of the NxStage System One and PureFlow SL dialysate preparation equipment, and sale of disposable products in the home and critical care markets. The home market focuses on the treatment of end-stage renal disease (ESRD) patients in the home or a home-like setting, and critical care market on the treatment of hospital-based patients with acute kidney failure or fluid overload. The In-Center segment sells blood tubing sets and needles for hemodialysis primarily for the treatment of ESRD patients at dialysis centers; and needles for apheresis. The Services segment provides dialysis services to patients at NxStage Kidney Care dialysis centers. NxStage Medical, Inc. markets its products through direct sales and distributors to hospitals and dialysis centers in the United States and internationally. The company, formerly known as QB Medical, Inc., was founded in 1998 and is headquartered in Lawrence, Massachusetts.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Nxstage Medical, Inc.

    Corporate Governance 
    Nxstage Medical, Inc.’s ISS Governance QuickScore as of Nov 1, 2015 is 5. The pillar scores are Audit: 2; Board: 4; Shareholder Rights: 5; Compensation: 6.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
    Mr. Jeffrey H. Burbank , 53
    Founder, Chief Exec. Officer and Director
    Mr. Joseph E. Turk Jr., 47
    Mr. Matthew W. Towse , 52
    Chief Financial Officer and Sr. VP
    Ms. Winifred L. Swan Esq., 51
    Sr. VP, Gen. Counsel and Sec.
    Mr. Robert S. Brown , 56
    Pres of Nxstage Kidney Care
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders